Department of Pharmacy Practice

College of Pharmacy
masthead

Michael Gabay

 Gabay
Michael Gabay, PharmD, JD, BCPS
Clinical Associate Professor
Director, Drug Information Center
Department of Pharmacy Practice
Email mgabay@uic.edu
Phone 312-413-3977
Fax 312-996-0448
Office B12 Pharm
US Mail 833 South Wood Street, RM164 MC886, Chicago, IL 60612

Research Interests
Dr. Gabay's areas of interest include drug information, legal issues related to healthcare, and prior authorization.

Education
2007 Doctor of Jurisprudence, Loyola University of Chicago College of Law
1999 Drug Information Specialty Residency, University of Illinois at Chicago Medical Center,Chicago, Illinois
1998 Pharmacy Practice Residency, Fairview-University Medical Center (formerly the University of Minnesota Hospital & Clinics)
1997 Doctor of Pharmacy, Bachelor of Science in Pharmacy, University of Minnesota, College of Pharmacy, Minneapolis, Minnesota
1993 Pre-pharmacy, University of Wisconsin - La Crosse, La Crosse, Wisconsin



Current UIC Appointments
 2007 to present

Director, Drug Information Group and Prior Authorization Programs


Representative Publications

  1. Ghaibi S, Ipema HJ, Gabay MG. ASHP guideline on the pharmacist’s role in providing drug information. Am J Health Syst Pharm. In press (scheduled September 2014).
  2. Gabay M.  A step forward: review of the new California Provider Status law.  Hosp Pharm. 2014;49(5):435-436.
  3. Gabay M.  Federal controlled substances act:  dispensing requirements, electronic prescriptions, and fraudulent prescriptions.  Hosp Pharm. 2014;49(3):244-246.
  4. Gabay M, Boucher BA.  An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis.  Pharmacotherapy. 2013;33(9):935-955.
  5. Gabay M.  Federal controlled substances act: ordering and recordkeeping.  Hosp Pharm. 2013;48(11):919-921.
  6. Gabay M.  Federal controlled substances act: controlled substances prescriptions.  Hosp Pharm. 2013;48(8):644-645.
  7. Gabay M.  The federal controlled substances act:  schedules and pharmacy registration.  Hosp Pharm. 2013;48(6):473-474.
  8. Gabay M.  Expanding the definition of nonprescription drugs: potential impact on pharmacists.  Hosp Pharm. 2013;48(3):198-199.
  9. Phillips JA, Gabay MP, Ficzere C, Ward KE. Curriculum and instructional methods for drug information, literature evaluation, and biostatistics: survey of US pharmacy schools. Ann Pharmacother. 2012;46(6):793-801.
  10. Gabay MP, Thakkar JP, Stachnik JM, Woelich SK, Villano JL. Intra-CSF administration of chemotherapy medications. Cancer Chemother Pharmacol. 2012;70(1):1-15.
  11. Stachnik J, Gabay M. Biologics in pediatrics. In: Field M, Boat T, eds. Supporting the Review of Best Pharmaceuticals for Children Act and Pediatric Research. Institute of Medicine of the National Academies. Released February 29, 2012. Available at: http://www.iom.edu/Reports/2012/Safe-and-Effective-Medicines-for-Children.aspx.
  12. Hong I, Gabay M, Lodolce A. Safety concerns involving transdermal patches and magnetic resonance imaging (MRI). Hosp Pharm. 2010;45(10):771-778.
  13. Sanborn M, Gabay M, Moody ML. The safety of intravenous drug delivery systems: update on current issues since the 1999 consensus development conference. Hosp Pharm. 2009;44(2):159-164.
  14. Gabay M, von Martius K. Comparative evaluation of collapsible versus semi-rigid intravenous containers. Technol Health Care. 2008;16(6):429-435.
  15. Gabay M. Absorbable hemostatic agents. Am J Health Syst Pharm. 2006;63(13):1244-1253.




















Click here to view Dr. Gabay's on-line CV. PDF logo

Return to faculty list